DI PASCOLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 3.173
AS - Asia 1.276
EU - Europa 794
AF - Africa 354
SA - Sud America 246
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 8
Totale 5.884
Nazione #
US - Stati Uniti d'America 3.008
SG - Singapore 467
CN - Cina 264
BR - Brasile 161
IT - Italia 161
HK - Hong Kong 124
VN - Vietnam 103
FI - Finlandia 69
DE - Germania 50
SE - Svezia 50
PL - Polonia 47
GB - Regno Unito 42
FR - Francia 36
RU - Federazione Russa 32
NL - Olanda 31
IN - India 27
TR - Turchia 25
UA - Ucraina 21
AT - Austria 20
CA - Canada 19
JP - Giappone 18
MD - Moldavia 18
ZA - Sudafrica 18
AR - Argentina 17
CZ - Repubblica Ceca 16
CI - Costa d'Avorio 15
BG - Bulgaria 13
BY - Bielorussia 13
CV - Capo Verde 13
DK - Danimarca 13
ES - Italia 13
AL - Albania 12
BF - Burkina Faso 12
DZ - Algeria 12
IE - Irlanda 12
IL - Israele 12
KG - Kirghizistan 12
KR - Corea 12
LB - Libano 12
MX - Messico 12
MY - Malesia 12
RW - Ruanda 12
TN - Tunisia 12
ZM - Zambia 12
AO - Angola 11
IQ - Iraq 11
MG - Madagascar 11
MW - Malawi 11
RE - Reunion 11
VE - Venezuela 11
AZ - Azerbaigian 10
BB - Barbados 10
CY - Cipro 10
DO - Repubblica Dominicana 10
EC - Ecuador 10
EG - Egitto 10
GN - Guinea 10
GT - Guatemala 10
ID - Indonesia 10
MA - Marocco 10
NZ - Nuova Zelanda 10
PS - Palestinian Territory 10
SA - Arabia Saudita 10
SN - Senegal 10
YT - Mayotte 10
AU - Australia 9
CM - Camerun 9
GE - Georgia 9
GM - Gambi 9
IS - Islanda 9
NE - Niger 9
PA - Panama 9
TL - Timor Orientale 9
VC - Saint Vincent e Grenadine 9
AE - Emirati Arabi Uniti 8
BD - Bangladesh 8
BE - Belgio 8
BJ - Benin 8
BW - Botswana 8
CO - Colombia 8
CR - Costa Rica 8
DJ - Gibuti 8
GH - Ghana 8
GP - Guadalupe 8
GR - Grecia 8
HN - Honduras 8
HU - Ungheria 8
LA - Repubblica Popolare Democratica del Laos 8
LU - Lussemburgo 8
LV - Lettonia 8
MN - Mongolia 8
MZ - Mozambico 8
PT - Portogallo 8
RO - Romania 8
SO - Somalia 8
TZ - Tanzania 8
ZW - Zimbabwe 8
AF - Afghanistan, Repubblica islamica di 7
BO - Bolivia 7
BS - Bahamas 7
Totale 5.582
Città #
Fairfield 496
Ashburn 345
Woodbridge 310
Houston 243
Singapore 227
Ann Arbor 224
Wilmington 163
Cambridge 155
Seattle 138
Chandler 129
Hong Kong 118
Beijing 83
Santa Clara 68
Padova 61
Boardman 55
Jacksonville 54
Princeton 48
San Diego 46
Bytom 35
Dong Ket 34
Medford 30
Helsinki 27
Los Angeles 27
Nanjing 26
Ho Chi Minh City 25
Des Moines 23
New York 23
Hanoi 20
São Paulo 18
Council Bluffs 17
Roxbury 17
Abidjan 15
Pune 15
Amsterdam 12
Brooklyn 12
London 12
Lusaka 12
Vienna 12
Chicago 11
Dallas 11
Johannesburg 11
Kigali 11
Praia 11
Antananarivo 10
Baku 10
Bishkek 10
Bridgetown 10
Conakry 10
Dakar 10
Dublin 10
Falkenstein 10
Guangzhou 10
Jinan 10
Montreal 10
Ouagadougou 10
Dili 9
Kingstown 9
Lilongwe 9
Munich 9
San Francisco 9
Chisinau 8
Cotonou 8
Djibouti 8
Guatemala City 8
Harare 8
Luanda 8
Niamey 8
Prague 8
Reykjavik 8
Riyadh 8
Sofia 8
Ulan Bator 8
Warsaw 8
Accra 7
Athens 7
Auckland 7
Dar es Salaam 7
Hebei 7
Kunming 7
Limassol 7
Managua 7
Milan 7
Minsk 7
Nanchang 7
Nassau 7
Panama City 7
Riga 7
Santo Domingo 7
Seoul 7
Shenyang 7
Tashkent 7
Tbilisi 7
Vientiane 7
Amman 6
Banjul 6
Boston 6
Cagliari 6
Changsha 6
Copenhagen 6
Dearborn 6
Totale 3.881
Nome #
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 235
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 229
Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report 201
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 199
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 198
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 176
Why and how to measure renal function in patients with liver disease 176
Clinical role of non-invasive assessment of portal hypertension 172
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 167
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 166
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 166
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 165
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 163
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis. 157
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase 156
Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts 150
Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance study 149
Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis 149
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats 143
Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis. 141
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis 138
Heme Oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites 134
Mitochondria-targeted antioxidant mitoquinone attenuates liver inflammation and fibrosis in cirrhotic rats 134
Renin-angiotensin-aldosterone system in cirrhosis: There's room to try! 132
Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3 131
Resveratrol administration improves intrahepatic endothelial dysfunction and reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats 130
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 128
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 127
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 120
Hepatic osteodystrophy. 119
Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats 116
EETs and HO-1 cross-talk 116
Cardiometabolic risk factors and clinical course of liver cirrhosis 111
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 111
Heme oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites 102
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites 94
Clinical role of non-invasive assessment of portal hypertension 91
Combined Pharmacological and Endoscopic Treatment for Worsening Gastroesophageal Varices in Patients with Cirrhosis 86
Prognostic value of procalcitonin in patients with cirrhosis hospitalized for acute infection 78
Prevention of endothelial cell dysfunction and apoptosis through the induction of heme oxygenase-1 normalizes blood pressure in diabetic spontaneously hypertensive rats 78
null 59
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis 53
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 51
Heme oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites. 48
Totale 5.945
Categoria #
all - tutte 19.626
article - articoli 18.775
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021400 0 0 0 0 0 17 31 50 72 133 43 54
2021/2022493 18 34 86 38 17 40 21 60 28 8 48 95
2022/2023287 72 24 0 20 66 34 1 17 20 4 25 4
2023/2024214 4 30 26 33 12 24 21 14 6 4 18 22
2024/2025921 1 41 42 39 111 39 78 72 56 39 176 227
2025/20262.006 184 266 564 606 379 7 0 0 0 0 0 0
Totale 5.945